Synergy between PI3K Signaling and MYC in Burkitt Lymphomagenesis

被引:244
作者
Sander, Sandrine [1 ,2 ,3 ]
Calado, Dinis P. [1 ,2 ,3 ]
Srinivasan, Lakshmi [1 ,2 ]
Koechert, Karl [3 ]
Zhang, Baochun [1 ,2 ]
Rosolowski, Maciej [4 ]
Rodig, Scott J. [5 ]
Holzmann, Karlheinz [6 ]
Stilgenbauer, Stephan [7 ]
Siebert, Reiner [8 ]
Bullinger, Lars [7 ]
Rajewsky, Klaus [1 ,2 ,3 ]
机构
[1] Harvard Univ, Sch Med, Program Cellular & Mol Med, Childrens Hosp, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA
[3] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany
[4] Univ Leipzig, Inst Med Informat Stat & Epidemiol, D-04107 Leipzig, Germany
[5] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[6] Univ Ulm, Microarray Core Facil, D-89081 Ulm, Germany
[7] Univ Hosp Ulm, Dept Internal Med 3, D-89081 Ulm, Germany
[8] Univ Kiel, Inst Human Genet, Univ Hosp Schleswig Holstein Campus Kiel, D-24105 Kiel, Germany
基金
美国国家卫生研究院; 欧洲研究理事会;
关键词
B-CELL LYMPHOMAS; CYCLIN D3; C-MYC; ACTIVATION; RECEPTOR; PATHOGENESIS; SIGNATURES; MICE; P53;
D O I
10.1016/j.ccr.2012.06.012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In Burkitt lymphoma (BL), a germinal center B-cell-derived tumor, the pro-apoptotic properties of c-MYC must be counterbalanced. Predicting that survival signals would be delivered by phosphoinositide-3-kinase (PI3K), a major survival determinant in mature B cells, we indeed found that combining constitutive c-MYC expression and PI3K activity in germinal center B cells of the mouse led to BL-like tumors, which fully phenocopy human BL with regard to histology, surface and other markers, and gene expression profile. The tumors also accumulate tertiary mutational events, some of which are recurrent in the human disease. These results and our finding of recurrent PI3K pathway activation in human BL indicate that deregulated c-MYC and PI3K activity cooperate in BL pathogenesis.
引用
收藏
页码:167 / 179
页数:13
相关论文
共 40 条
[1]   MYC ONCOGENE ACTIVATION IN B-LYMPHOID AND T-LYMPHOID TUMORS [J].
ADAMS, JM ;
CORY, S .
PROCEEDINGS OF THE ROYAL SOCIETY SERIES B-BIOLOGICAL SCIENCES, 1985, 226 (1242) :59-72
[2]   Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling [J].
Alizadeh, AA ;
Eisen, MB ;
Davis, RE ;
Ma, C ;
Lossos, IS ;
Rosenwald, A ;
Boldrick, JG ;
Sabet, H ;
Tran, T ;
Yu, X ;
Powell, JI ;
Yang, LM ;
Marti, GE ;
Moore, T ;
Hudson, J ;
Lu, LS ;
Lewis, DB ;
Tibshirani, R ;
Sherlock, G ;
Chan, WC ;
Greiner, TC ;
Weisenburger, DD ;
Armitage, JO ;
Warnke, R ;
Levy, R ;
Wilson, W ;
Grever, MR ;
Byrd, JC ;
Botstein, D ;
Brown, PO ;
Staudt, LM .
NATURE, 2000, 403 (6769) :503-511
[3]   Evolution of neoplastic cell lineages in Barrett oesophagus [J].
Barrett, MT ;
Sanchez, CA ;
Prevo, LJ ;
Wong, DJ ;
Galipeau, PC ;
Paulson, TG ;
Rabinovitch, PS ;
Reid, BJ .
NATURE GENETICS, 1999, 22 (01) :106-109
[4]   Estimation and assessment of raw copy numbers at the single locus level [J].
Bengtsson, H. ;
Irizarry, R. ;
Carvalho, B. ;
Speed, T. P. .
BIOINFORMATICS, 2008, 24 (06) :759-767
[5]  
BHATIA KG, 1992, CANCER RES, V52, P4273
[6]   Oncogenic pathway signatures in human cancers as a guide to targeted therapies [J].
Bild, AH ;
Yao, G ;
Chang, JT ;
Wang, QL ;
Potti, A ;
Chasse, D ;
Joshi, MB ;
Harpole, D ;
Lancaster, JM ;
Berchuck, A ;
Olson, JA ;
Marks, JR ;
Dressman, HK ;
West, M ;
Nevins, JR .
NATURE, 2006, 439 (7074) :353-357
[7]   Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge [J].
Boerma, E. G. ;
Siebert, R. ;
Kluin, P. M. ;
Baudis, M. .
LEUKEMIA, 2009, 23 (02) :225-234
[8]   Constitutive Canonical NF-κB Activation Cooperates with Disruption of BLIMP1 in the Pathogenesis of Activated B Cell-like Diffuse Large Cell Lymphoma [J].
Calado, Dinis Pedro ;
Zhang, Baochun ;
Srinivasan, Lakshmi ;
Sasaki, Yoshiteru ;
Seagal, Jane ;
Unitt, Christine ;
Rodig, Scott ;
Kutok, Jeffery ;
Tarakhovsky, Alexander ;
Schmidt-Supprian, Marc ;
Rajewsky, Klaus .
CANCER CELL, 2010, 18 (06) :580-589
[9]   P38SAPK2 phosphorylates cyclin D3 at Thr-283 and targets it for proteasomal degradation [J].
Casanovas, O ;
Jaumot, M ;
Paules, AB ;
Agell, N ;
Bachs, O .
ONCOGENE, 2004, 23 (45) :7537-7544
[10]   Tracking germinal center B cells expressing germ-line immunoglobulin γ1 transcripts by conditional gene targeting [J].
Casola, Stefano ;
Cattoretti, Giorgio ;
Uyttersprot, Nathalie ;
Koralov, Sergei B. ;
Segal, Jane ;
Hao, Zhenyue ;
Waisman, Ari ;
Egert, Angela ;
Ghitza, Dvora ;
Rajewsky, Klaus .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (19) :7396-7401